Sangamo BioSciences Firms Nearly 3% After HIVAIDS Treatment

Local News
2.9K
126 views
  • About
  • Add to
Sangamo BioSciences (SGMO) is up after it says data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIVAIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and Opportunistic Infections.

0 comments